Exercise and Post-dry Needling Soreness

NCT ID: NCT02558686

Last Updated: 2016-01-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-10-31

Study Completion Date

2016-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Application of trigger point dry needling can induce post-dry needling soreness. This is not a negative experience, but sometimes some patients want to reduce it as much as possible. Manual therapies and exercise strategies targeting to decrease post-dry needling soreness need to be investigated.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Shoulder Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Eccentric Exercise

Individuals will perform 3 sets of 10 repetitions of eccentric exercise of the infraspinatus muscle after the application of trigger point dry needling

Group Type EXPERIMENTAL

Eccentric Exercise

Intervention Type OTHER

Individuals will perform 3 sets of 10 repetitions of eccentric exercise of the infraspinatus muscle after the application of trigger point dry needling

Detuned Ultrasound

Individuals will received 10 minutes of detuned ultrasound on the infraspinatus muscle after the application of trigger point dry needling

Group Type SHAM_COMPARATOR

Detuned Ultrasound

Intervention Type OTHER

Individuals will received 10 minutes of detuned ultrasound on the infraspinatus muscle after the application of trigger point dry needling

Placebo

Individuals will not perform any action after the application of trigger point dry needling

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type OTHER

Individuals will not perform any action after the application of trigger point dry needling

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Eccentric Exercise

Individuals will perform 3 sets of 10 repetitions of eccentric exercise of the infraspinatus muscle after the application of trigger point dry needling

Intervention Type OTHER

Detuned Ultrasound

Individuals will received 10 minutes of detuned ultrasound on the infraspinatus muscle after the application of trigger point dry needling

Intervention Type OTHER

Placebo

Individuals will not perform any action after the application of trigger point dry needling

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Unilateral non-traumatic shoulder pain
* Shoulder pain from at least 6 months
* Shoulder pain of more than 3 points on a NPRS
* Presence of active trigger point in the infraspinatus muscle

Exclusion Criteria

* bilateral shoulder pain
* younger than 18 or older than 65 years
* shoulder injury
* upper extremity surgery
* fibromyalgia syndrome
* neck or shoulder surgery
* cervical radiculopathy
* whiplash
* any type of intervention for the neck-shoulder the previous year
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidad Rey Juan Carlos

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

César Fernández-de-las-Peñas

Head Division

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Cesar Fernández-de-las-Peñas, PhD

Role: PRINCIPAL_INVESTIGATOR

Universidad Rey Juan Carlos

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Universidad Rey Juan Carlos

Alcorcón, Madrid, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

URJC 2015-12

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.